PMA supplement
P810046 S218: CROSSSAIL, OPENSAIL, RX CHASSIS I & III AND VOYAGER CORONARY DILATATION CATHETERS
FDA PMA supplement · 30-Day Notice · Advanced Cardiovascular Systems, Inc.
Key facts
| Original PMA | P810046 |
|---|---|
| Supplement number | S218 |
| Supplement type | 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | CROSSSAIL, OPENSAIL, RX CHASSIS I & III AND VOYAGER CORONARY DILATATION CATHETERS |
| Generic name | STENT, CORONARY |
| Applicant | Advanced Cardiovascular Systems, Inc. |
| Product code | MAF |
| Received date | Dec 21, 2004 |
| Decision date | Jan 14, 2005 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: